DexCom Earnings
NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
After market close
Fiscal period
Sep/2026
EPS estimate
$0.66
DexCom earnings summary
DexCom is scheduled to report Sep/2026 earnings on Oct 29, 2026 after the market closes, with analysts expecting EPS of $0.66. In its most recent report on Jul 30, 2026 (Q2 2026), DXCM posted EPS of $0.64. Revenue for the quarter was $1.31 billion.
Quarterly EPS is up 42.2% from the same quarter a year earlier. Across the last 16 reports, DXCM shares moved an average of 4.2% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
DXCM earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $0.64 | — | +1.6% |
| Apr 30, 2026 | — | $0.51 | — | -1.2% |
| Feb 12, 2026 | — | $0.67 | — | +4.4% |
| Oct 30, 2025 | — | $0.70 | — | -5.5% |
| Jul 30, 2025 | — | $0.45 | — | -0.5% |
| May 1, 2025 | — | $0.27 | — | +3.7% |
| Feb 18, 2025 | — | $0.37 | — | -0.5% |
| Oct 24, 2024 | — | $0.34 | — | -4.2% |
| Jul 25, 2024 | — | $0.35 | — | +13.0% |
| Apr 25, 2024 | — | $0.36 | — | +3.2% |
| Feb 8, 2024 | — | $0.61 | — | -2.8% |
| Oct 26, 2023 | — | $0.29 | — | +9.1% |
| Jul 27, 2023 | — | $0.28 | — | -9.1% |
| Apr 27, 2023 | — | $0.12 | — | -0.4% |
| Feb 9, 2023 | — | $0.23 | — | -2.7% |
| Oct 27, 2022 | — | $0.24 | — | -5.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.